US 9273121
Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9273121 (Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K47/6841, A61P